Cláudia Silva
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 2
-
- Alcohol Consumption and Health Effects 2
-
- Lung Cancer Treatments and Mutations 4
-
- Cancer therapeutics and mechanisms 2
-
- HER2/EGFR in Cancer Research 2
-
- Quinazolinone synthesis and applications 2
-
- Diagnosis and Treatment of Venous Diseases 2
-
- Genetic Syndromes and Imprinting 1
- Co-authors
- Jianxiong WangV. Wee YongScott SlokaJianhua GongPeter F. BarnesDajun QianMarco MorFederica Vacondio
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)
- Partner nations
- PortugalItalyUnited States
In The Last Decade
Cláudia Silva
22 papers receiving 665 citations
Peers
Comparison fields: 5 of 103
- Infectious Diseases 232
- Virology 32
- Pathology and Forensic Medicine 111
- Epidemiology 213
- Immunology 104
Countries citing papers authored by Cláudia Silva
This map shows the geographic impact of Cláudia Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cláudia Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cláudia Silva more than expected).
Fields of papers citing papers by Cláudia Silva
This network shows the impact of papers produced by Cláudia Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cláudia Silva. The network helps show where Cláudia Silva may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cláudia Silva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 11 | |
| 3 | 2022 | 0 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 0 | |
| 9 | 2018 | 11 | |
| 10 | 2015 | 27 | |
| 11 | 2014 | 84 | |
| 12 | 2013 | 3 | |
| 13 | 2012 | 46 | |
| 14 | 2012 | 18 | |
| 15 | 2012 | 5 | |
| 16 | 2011 | 116 | |
| 17 | 2006 | 14 | |
| 18 | 2005 | 109 | |
| 19 | 2003 | 48 | |
| 20 | 1997 | 127 |
About Cláudia Silva
Cláudia Silva is a scholar working on Complementary and Manual Therapy, Pathology and Forensic Medicine and Internal Medicine, having authored 24 papers that have together received 686 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer therapeutics and mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers), Tuberculosis Research and Epidemiology (2 papers), Quinazolinone synthesis and applications (2 papers), Alcohol Consumption and Health Effects (2 papers), Diagnosis and Treatment of Venous Diseases (2 papers) and Genetic Syndromes and Imprinting (1 paper). The work is most often cited by research in Infectious Diseases (232 citations), Virology (32 citations) and Pathology and Forensic Medicine (111 citations). Cláudia Silva has collaborated with scholars based in Portugal, Italy and United States. Frequent co-authors include Jianxiong Wang, V. Wee Yong, Scott Sloka, Jianhua Gong, Peter F. Barnes, Dajun Qian, Marco Mor, Federica Vacondio, Alessio Lodola and Michele Bassi. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.